Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-01-16 5:22 pm Purchase | 13D | XOMA CORP COM XOMA | BIOTECHNOLOGY VALUE FUND L P | 3,633,743 31.6% | 103,200 (+2.92%) | View |
| 2024-01-09 4:45 pm Purchase | 13D | KYMERA THERAPEUTICS INC KYMR | BIOTECHNOLOGY VALUE FUND L P | 5,831,171 9.99% | 1,138,567 (+24.26%) | View |
| 2023-12-20 4:38 pm Sale | 13D | POINT BIOPHARMA GLOBAL INC PNT | BIOTECHNOLOGY VALUE FUND L P | 0 0% | -17,437,375 (Position Closed) | View |
| 2023-12-20 4:36 pm Sale | 13G | STRUCTURE THERAPEUTICS INC SPO GPCR | BIOTECHNOLOGY VALUE FUND L P | 2,438,964 1.8% | -10,221,554 (-80.74%) | View |
| 2023-12-19 4:53 pm Purchase | 13G | AC IMMUNE SA SHS ACIU | BIOTECHNOLOGY VALUE FUND L P | 14,571,236 14.8% | 7,142,857 (+96.16%) | View |
| 2023-12-18 4:35 pm Unchanged | 13D | RAIN ONCOLOGY INC. RAIN | BIOTECHNOLOGY VALUE FUND L P | 3,526,729 12.8% | 0 (Unchanged) | View |
| 2023-12-04 4:33 pm Purchase | 13G | SAB BIOTHERAPEUTICS INC SABS | BIOTECHNOLOGY VALUE FUND L P | 9,178,282 9.99% | 9,178,282 (New Position) | View |
| 2023-11-20 5:07 pm Purchase | 13D | MOLECULAR PARTNERS AG ADS MOLN | BIOTECHNOLOGY VALUE FUND L P | 8,696,205 23.9% | 2,203,688 (+33.94%) | View |
| 2023-11-17 4:52 pm Purchase | 13D | REPARE THERAPEUTICS INC RPTX | BIOTECHNOLOGY VALUE FUND L P | 10,333,600 24.5% | 1,235,000 (+13.57%) | View |
| 2023-11-13 4:45 pm Purchase | 13G | ENGENE HLDGS INC ENGN | BIOTECHNOLOGY VALUE FUND L P | 3,196,439 13.2% | 3,196,439 (New Position) | View |
| 2023-11-07 4:41 pm Purchase | 13G | MOLECULAR PARTNERS AG ADS MOLN | BIOTECHNOLOGY VALUE FUND L P | 6,492,517 17.9% | 1,982,445 (+43.96%) | View |
| 2023-11-06 1:47 pm Purchase | 13D | POINT BIOPHARMA GLOBAL INC PNT | BIOTECHNOLOGY VALUE FUND L P | 17,437,375 16.5% | 8,259,627 (+90.00%) | View |
| 2023-11-03 5:20 pm Purchase | 13D | REPARE THERAPEUTICS INC RPTX | BIOTECHNOLOGY VALUE FUND L P | 9,098,600 21.6% | 806,612 (+9.73%) | View |
| 2023-10-16 4:34 pm Purchase | 13G | VISTAGEN THERAPEUTICS INC VTGN | BIOTECHNOLOGY VALUE FUND L P | 2,777,245 9.99% | 2,777,245 (New Position) | View |
| 2023-09-25 4:35 pm Purchase | 13D | INVENTIVA SA ADR IVA | BIOTECHNOLOGY VALUE FUND L P | 8,545,499 16.5% | 587,361 (+7.38%) | View |
| 2023-09-18 4:35 pm Purchase | 13G | MIRUM PHARMACEUTICALS INC MIRM | BIOTECHNOLOGY VALUE FUND L P | 4,370,024 9.4% | 4,370,024 (New Position) | View |
| 2023-09-14 4:23 pm Purchase | 13D | OLEMA PHARMACEUTICALS INC OLMA | BIOTECHNOLOGY VALUE FUND L P | 9,135,893 16.7% | 1,724,390 (+23.27%) | View |
| 2023-08-17 4:52 pm Unchanged | 13D | RAIN ONCOLOGY INC. RAIN | BIOTECHNOLOGY VALUE FUND L P | 3,526,729 12.8% | 0 (Unchanged) | View |
| 2023-08-17 4:49 pm Unchanged | 13D | PIERIS PHARMACEUTICALS INC PIRS | BIOTECHNOLOGY VALUE FUND L P | 20,609,863 20.8% | 0 (Unchanged) | View |
| 2023-08-10 4:34 pm Purchase | 13G | FORTE BIOSCIENCES FBRX | BIOTECHNOLOGY VALUE FUND L P | 2,982,105 8.2% | 2,982,105 (New Position) | View |